Intravesical recombinant BCG combined with chemo-immunotherapy (chemo-IO) as perioperative therapy for patients with muscle-invasive bladder cancer (MIBC): Primary analysis of SAKK 06/19.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, Lukas Bubendorf, Martin Spahn, Philipp Niederberger, Frank Stenner, Anita Hirschi, Ursula Vogl, Anja Lorch, Petros Tsantoulis, Stefanie Aeppli, Andreas Erdmann, Raeto Strebel, Angela Fischer Maranta, Christian Daniel Fankhauser, Sabrina Chiquet, Sacha I. Rothschild, Cyrill Rentsch
Institutions: Kantonsspital Graubünden, GastroZentrum Hirslanden Zürich, University Hospital of Basel, Lindenhofspital, Luzerner Kantonsspital, Klinik Hirslanden, Ente Ospedaliero Cantonale, Istituto Oncologico della Svizzera Italiana, University Hospital Zurich, University Hospital of Geneva, Kantonsspital St. Gallen, Kantonsspital Baden, University of Basel
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162535402
Cites:
Cited by:
Related to: